Category Archives: stem cell research

http://medicalxpress.com/news/2012-05-fish-spinal-injury.html (Medical Xpress) — Scientists have unlocked the secrets of the zebra fish’s ability to heal its spinal cord after injury, in research that could deliver therapy for paraplegics and quadriplegics in the future.

http://www.news.wisc.edu/21746 by David Tenenbaum A UW-Madison research group has converted skin cells from people and monkeys into a cell that can form a wide variety of nervous-system cells — without passing through the do-it-all stage called the induced pluripotent stem cell, or iPSC.

http://www.kvoa.com/news/uamc-trauma-center-to-study-drug-that-may-improve-function-after-spinal-cord-injury/ TUCSON – A new drug that may improve function after acute spinal cord injury has been chosen for clinical study at the University of Arizona Medical Center Trauma Center. UAMC is one of 60 trauma centers in the United States, Canada and Europe selected to conduct a clinical trial…

http://www.massdevice.com/invivo-therapeutics-touts-case-study-1st-spine-scaffold-implant/ InVivo TherapeuticsInVivo Therapeutics (NSDQ:NVIV) this week touted a case study of the 1st implantation of its spinal scaffold, a bioresorbable device designed to help treat traumatic spinal cord injuries. The study, published in Neurosurgery, the journal of the Congress of Neurological Surgeon…

https://globenewswire.com/news-release/2017/08/23/1091407/0/en/Asterias-Biotherapeutics-Opens-Additional-Clinical-Site-for-AST-OPC1-SCiStar-Study.html Source: Asterias Biotherapeutics FREMONT, Calif., Aug. 23, 2017 (GLOBE NEWSWIRE) — Asterias Biotherapeutics, Inc. (NYSE MKT:AST), a biotechnology company pioneering the field of regenerative medicine, today announced that Washington University School of Medicine in St. Louis, MO, has been added as a clinical site in the company’s ongoing SCiStar Phase 1/2a clinical trial ofContinue reading “Asterias Biotherapeutics Opens Additional Clinical Site for AST-OPC1 SCiStar Study”

https://www.abc.net.au/news/health/2018-11-01/neurotechnology-restores-walking-spinal-cord-injury/10446050 Three patients with severe spinal cord injuries are walking again, thanks to a wireless implant which delivers electrical stimulation to the spinal cord. A team based at the Swiss Federal Institute of Technology (EPFL) surgically implanted spinal cord stimulators in the patients, with the aim of activating the spinal cord via an electrical pulse.

https://medicalxpress.com/news/2020-09-path-neuron-regeneration-spinal-cord.html Dynamic networks that specialize in the transmission of information generally consist of multiple components, including not only primary processors, like computers, for example, but also numerous support applications and services. The human nervous system is…

http://www.allheadlinenews.com/articles/7006073389 <P>By Linda Young, January 8, 2007 (All Headline News)- A breakthrough in producing stem cells for research from amniotic fluid rather than aborted fetuses might be good news for people suffering from disease, including Parkinson’s and Alzheimer’s. That new source of stem cells for research could lead to more research being done. </P> <P>CurrentlyContinue reading “Study: Non-Controversial Source of Stem Cells Found For Research”

http://sev.prnewswire.com/health-care-hospitals/20071101/AQTH13301112007-1.html <p>Nov. 1, 2007 (PRNewswire.com)- Today, Cryo-Cell announced its discovery of a new, unique type of stem cell found in menstrual blood that may one day have the potential to treat a number of diseases. Cryo-Cell also launched an exclusive and proprietary new service, called C’elle, to enable women to collect and cryopreserve their menstrualContinue reading “News at a Glance: Promising Stem Cells Discovered in Menstrual Blood; Cryo-Cell Launches World’s First-Ever Collection and Storage Service, C’elle”

http://www.cnn.com/2009/HEALTH/01/23/stem.cell/ <p><br /> (CNN) — Federal regulators have cleared the way for the first human trials of human embryonic stem-cell research, authorizing researchers to test whether the cells are safe to use in spinal injury patients, the company behind the trials announced Friday.</p> <p><br /> Embryonic stem cells are blank cells found in embryos, whichContinue reading “FDA approves human embryonic stem cell study”

http://www.msnbc.msn.com/id/33379793/ns/health-more_health_news/ <p>CHICAGO – A common antidepressant combined with an intensive treadmill training program helped people with partial spinal cord injuries walk better and faster, U.S. researchers said.</p> <p>They said Forest Laboratories’ antidepressant Lexapro or escitalopram, which affects a message-carrying brain chemical called serotonin, helps strengthen…</p>

http://www.businesswire.com/portal/site/home/permalink/?ndmViewId=news_view&newsId=20100804006365&newsLang=en <p>COVINGTON, La.–(BUSINESS WIRE)–TCA Cellular Therapy, LLC has enrolled its first patient to participate in the U.S. Food and Drug Administration (FDA) first adult stem cell clinical trial to treat spinal cord injuries. Enrollee and Marine Veteran, Matt Cole was paralyzed from the chest down in a 2005 insurgent attack in Iraq.</p> <p>&ldquo;I&rsquo;m very encouragedContinue reading “Paralyzed Iraqi War Veteran Will Be First to Receive Adult Stem Cells to Treat Spinal Cord Injuries at TCA Cellular Therapy”

http://www.mercurynews.com/bay-area-news/ci_19542843 Julia Prodis Sulek Katie Sharify, 23, of Pleasanton, does physical therapy in the spinal cord.nbsp; Paralyzed from the torso down, Katie Sharify heads home from Santa Clara Valley Medical Center on Wednesday, daring to hope that the 2 million stem cells creeping up her damaged…

http://www.asianscientist.com/health-medicine/clinical-study-blocks-protein-treat-spinal-cord-injury-2013/ Researchers in Australia will begin clinical trials for spinal cord injury by blocking a protein called EphA4. Researchers at the Queensland Brain Institute (QBI), the Queensland Institute of Medical Research (QIMR), and the University of Melbourne showed in the Journal of Neurotrauma that blocking protein EphA4 could rapidly restore the balance and limb coordinationContinue reading “Researchers in Australia will begin clinical trials for spinal cord injury by blocking a protein called EphA4.”

http://www.marketwatch.com/story/stemcells-inc-initiates-phase-ii-clinical-trial-in-cervical-spinal-cord-injury-2014-10-07 StemCells, Inc. STEM, -3.17% a world leader in the research and development of cell based therapies for the treatment of disorders of the central nervous system, announced today that it has initiated its Pathway® Study, a Phase II proof of concept clinical trial using its proprietary HuCNS-SC® platform of human neural stem cells forContinue reading “StemCells, Inc. Initiates Phase II Clinical Trial in Cervical Spinal Cord Injury”